Javier Cifuentes
Overview
Explore the profile of Javier Cifuentes including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
32
Citations
328
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
Lopez-Barbosa N, Suarez-Arnedo A, Cifuentes J, Gonzalez Barrios A, Silvera Batista C, Osma J, et al.
ACS Biomater Sci Eng
. 2021 Jan;
6(1):415-424.
PMID: 33463215
Outer membrane protein A (OmpA) has been extensively studied in Gram-negative bacteria due to its relevance in the adhesion of pathogens to host cells and its surfactant capabilities. It consists...
22.
Ramirez-Acosta C, Cifuentes J, Cruz J, Reyes L
Nanomaterials (Basel)
. 2020 Sep;
10(9).
PMID: 32957444
Nanomedicine is entering a high maturity stage and is ready to reach full translation into the clinical practice. This is because of the ample spectrum of applications enabled by a...
23.
Rueda-Gensini L, Cifuentes J, Castellanos M, Puentes P, Serna J, Munoz-Camargo C, et al.
Nanomaterials (Basel)
. 2020 Sep;
10(9).
PMID: 32932957
Iron oxide nanoparticles (IONs) have been widely explored for biomedical applications due to their high biocompatibility, surface-coating versatility, and superparamagnetic properties. Upon exposure to an external magnetic field, IONs can...
24.
Ramirez-Acosta C, Cifuentes J, Castellanos M, Moreno R, Munoz-Camargo C, Cruz J, et al.
Pharmaceutics
. 2020 Jun;
12(6).
PMID: 32560390
Over the past decade, gene therapies have attracted much attention for the development of treatments for various conditions, including cancer, neurodegenerative diseases, protein deficiencies, and autoimmune disorders. Despite the benefits...
25.
Lopez-Barbosa N, Garcia J, Cifuentes J, Castro L, Vargas F, Ostos C, et al.
Drug Deliv
. 2020 Jun;
27(1):864-875.
PMID: 32515999
Therapeutic drugs for Alzheimer's disease have been extensively studied due to its recurrence and abundance among neurodegenerative diseases. It is thought that the accumulation of amyloid precursor protein (APP) products,...
26.
Palma E, Armijo I, Cifuentes J, Ambiado S, Rochet P, Diaz B, et al.
J Reprod Infant Psychol
. 2020 Apr;
39(1):30-42.
PMID: 32223427
: To compare prenatal attachment in women hospitalised due to high-risk pregnancy with prenatal attachment in non-hospitalised patients. To describe the impact of social support, socio-demographic factors and the nature...
27.
Perez J, Cifuentes J, Cuellar M, Suarez-Arnedo A, Cruz J, Munoz-Camargo C
Int J Nanomedicine
. 2019 Nov;
14:8483-8497.
PMID: 31695376
Introduction: Controlled delivery of therapeutic molecules in a localized manner has become an area of interest due to its potential to reduce drug exposure to healthy tissues and consequently to...
28.
Fernandez-Nino M, Rojas L, Cifuentes J, Torres R, Ordonez A, Cruz J, et al.
PLoS One
. 2019 Oct;
14(10):e0223670.
PMID: 31600354
The Escherichia coli's membrane protein OmpA has been identified as a potential biosurfactant due to their amphiphilic nature, and their capacity to stabilize emulsions of dodecane in water. In this...
29.
Cuellar M, Cifuentes J, Perez J, Suarez-Arnedo A, Serna J, Groot H, et al.
Int J Nanomedicine
. 2018 Dec;
13:8087-8094.
PMID: 30568447
Introduction: One of the major challenges of modern pharmacology is the development of systems for the delivery of therapeutic molecules in a controlled and localized manner. One strategy is to...
30.
Layliev J, Gill R, Spear M, Cifuentes J, Wang L, Kelly K
J Craniofac Surg
. 2016 Jun;
27(6):1445-52.
PMID: 27300462
There is a lack of consensus on the optimal timing for primary cranial vault reconstruction in cranial synostosis. The purpose of this study was to assess the impact of age...